Search clinical trials for: Amatuximab
Total 96 results
-
National Cancer Institute (NCI)TerminatedCarcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Mesothelioma | Carcinoma, Pancreatic DuctalUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Cryoglobulinemic Vasculitis
-
Thomas Martin, MDWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Firas El Chaer, MDRecruitingHematologic Malignancy | Platelet RefractorinessUnited States
-
Memorial Sloan Kettering Cancer CenterSanofiRecruitingBlood Cancer | Refractory Immune CytopeniasUnited States
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
MorphotekCompletedPancreatic Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung CancerUnited States
-
Karolinska InstitutetSanofi; XNK Therapeutics AB, SwedenRecruiting
-
SanofiCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaUnited States, Czechia, France
-
SanofiCompleted
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingNausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary AmyloidosisUnited States
-
Canadian Myeloma Research GroupActive, not recruiting
-
MorphotekCompletedMalignant Pleural MesotheliomaUnited States, Canada, Germany, Spain, Netherlands
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Eastern Hepatobiliary Surgery HospitalCompletedHepatocellular CarcinomaChina
-
MorphotekTerminatedMesothelioma, MalignantFrance, United Kingdom, United States, Germany, Australia, Italy
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
NYU Langone HealthNot yet recruitingAntibody-mediated Rejection | AllosensitizationUnited States
-
Tufts Medical CenterSanofiWithdrawnAmyloidosis | Light Chain (AL) Amyloidosis
-
SanofiTerminatedLymphomaKorea, Republic of, Portugal, France, Taiwan, Italy, Netherlands, Spain
-
Deborah Yurgelun-ToddCompletedNeurocognitive ImprovementUnited States
-
OHSU Knight Cancer InstituteSanofi; Oregon Health and Science UniversityActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
University of Texas Southwestern Medical CenterStanley Medical Research InstituteCompletedBipolar Disorder | Major Depressive Disorder | Amphetamine Dependence | Amphetamine AbuseUnited States
-
University of Illinois at ChicagoRecruiting
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
SanofiTerminatedNeoplasmSpain, Taiwan, Italy, Czechia, United States, Belgium, Canada, Netherlands
-
University Hospitals Coventry and Warwickshire...University of Warwick; University of Birmingham; Kingston UniversityUnknown
-
Dong-A Pharmaceutical Co., Ltd.UnknownAcute Gastritis | Chronic GastritisKorea, Republic of
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
SanofiActive, not recruitingMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Clinical Institute of the Brain, RussiaEver Neuro Pharma GmbH; Nycomed; VeropharmCompleted
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Sanofi; AmgenActive, not recruiting
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
EMN Research ItalyActive, not recruitingRelapsed Multiple MyelomaItaly
-
University of Heidelberg Medical CenterBristol-Myers Squibb; Sanofi; Wuerzburg University Hospital; KKS NetzwerkRecruiting
-
Laval UniversityNational Cancer Institute (NCI); Canadian Cancer Trials GroupCompleted
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
Kyowa Hakko Bio Co., Ltd.Oregon Health and Science UniversityCompleted
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Canadian Myeloma Research GroupNot yet recruiting
-
Hoffmann-La RocheTerminatedColorectal CancerUnited States, Korea, Republic of, Australia, France, Switzerland